1087302

Covis Pharma GmBH — FEI 3008152278

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 5, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Waltham, MA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)